Piyush Ranjan

Dr. Piyush Ranjan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SDSuvashis Dash
Suvashis Dash
SSSaugata Samadder
Saugata Samadder
ASAnurag Srivastava
Anurag Srivastava
RMRajendra Meena
Rajendra Meena
PRPiyush Ranjan
Piyush Ranjan

15 March 2020 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
KLKush Raj Lohani
Kush Raj Lohani
CKChitresh Kumar
Chitresh Kumar
KKKamal Kataria
Kamal Kataria
ASAnurag Srivastava
Anurag Srivastava
PRPiyush Ranjan
Piyush Ranjan
ADAnita Dhar
Anita Dhar


1 June 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
SPSheetal Pathania
Sheetal Pathania
MKMohd Imran Khan
Mohd Imran Khan
AKAbhishek Kumar
Abhishek Kumar
AGAshish Kumar Gupta
Ashish Kumar Gupta
KRKomal Rani
Komal Rani
GHGururao Hariprasad
Gururao Hariprasad
Introduction: Breast cancer is the second most common cancer in women across the world. Some of the patients who present in the early stage of disease are affected by metastasis to the axillary group of lymph nodes. The first among this group that is affected is called as sentinel lymph node, and its diagnosis is crucial for the staging of cancer thereby dictating the type of surgical therapy. Therefore, the sentinel lymph node status provides the most relevant information to the surgeon and patient prognosis. The expanded utilization of breast conservation surgery has declined the morbidity associated with mastectomy and axillary lymph node surgery. Recent interest is, therefore, centered on techniques that allow accurate assessment of the sentinel lymph node metastasis. A current procedure such as sentinel lymph node biopsy (SLNB) that is used to assess axillary lymph node metastasis is neither specific nor sensitive, and besides, it is time-consuming. Objective: To compare the protein profiles between metastatic and non-metastatic lymph nodes to identify a biomarker that can flag lymph node metastasis. Materials and Methods: Women with early breast cancer were screened using mammography imaging and recruited to the study. Surgical resection was done to remove the breast tissue, and sentinel lymph node was identified using fluorescein and methylene blue tracer. Lymph node was sliced, and one set was sent for histopathology, which was considered the gold standard to assess the metastatic status of the lymph node. One set of slices was taken for proteomic experiments. Proteins were labelled with fluorescent cyanine tags and were subjected to difference gel electrophoresis experiment. Differentially expressed spots that had at least a twofold relative ratio and consistent pattern across three sets of biological replicate experiments were marked. Gel spots were trypsin digested and identified on mass spectrometry machine. Validation study was done by Western blot experiment on the same set of samples. Results: Thymidylate synthase has a twofold higher expression in the metastatic sentinel lymph nodes as compared to non-metastatic lymph nodes in early breast cancer patients. Conclusion: Differential in gel expression proteomics is an ideal platform for the identification of potential protein biomarker candidates that can differentiate metastatic from non-metastatic lymph nodes in early breast cancer. The identification of thymidylate synthase offers a scope to develop an on-table diagnostic kit to assess the status of sentinel lymph nodes during mastectomy procedure to guide surgical management of axillary lymph nodes in early breast cancer.


11 March 2021 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
KLKush Raj Lohani
Kush Raj Lohani
CKChitresh Kumar
Chitresh Kumar
KKKamal Kataria
Kamal Kataria
ASAnurag Srivastava
Anurag Srivastava
PRPiyush Ranjan
Piyush Ranjan
ADAnita Dhar
Anita Dhar